It may not be "kind or fair"--business rarely is--but a good, solid company that's currently in a world of hurt (RNA) is usually a ripe target for a buyout.
There's got to be some amound of premium. IMHO SRPT would get a steal at $6 per share, and I don't think RNA shareholders can hope for more than $8. Either number would be great for current short-term traders.